Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
PDB ID | HET | Uniprot Name | EC Number |
---|---|---|---|
4hnf | 16W | Casein kinase I isoform delta | 2.7.11.1 |
PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
---|---|---|---|---|---|
4hnf | 16W | Casein kinase I isoform delta | 2.7.11.1 | 1.000 | |
3uyt | 0CK | Casein kinase I isoform delta | 2.7.11.1 | 0.587 | |
4kbk | 1QG | Casein kinase I isoform delta | 2.7.11.1 | 0.587 | |
4kb8 | 1QN | Casein kinase I isoform delta | 2.7.11.1 | 0.555 | |
2izr | BRK | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.545 | |
4yuq | KS1 | Calmodulin-like domain protein kinase | / | 0.543 | |
4i22 | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.538 | |
4hni | 16W | Casein kinase I isoform epsilon | 2.7.11.1 | 0.537 | |
1eh4 | IC1 | Casein kinase I homolog 1 | 2.7.11.1 | 0.535 | |
4g17 | 0VN | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.532 | |
4kba | 1QM | Casein kinase I isoform delta | 2.7.11.1 | 0.530 | |
4bid | IE8 | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.529 | |
3uzp | 0CK | Casein kinase I isoform delta | 2.7.11.1 | 0.528 | |
3gub | GUB | Death-associated protein kinase 1 | 2.7.11.1 | 0.526 | |
2wot | ZZG | TGF-beta receptor type-1 | 2.7.11.30 | 0.523 | |
3gxl | QIG | TGF-beta receptor type-1 | 2.7.11.30 | 0.523 | |
3fln | 3FN | Mitogen-activated protein kinase 14 | / | 0.521 | |
2izs | BRQ | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.511 | |
2b1p | AIZ | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.508 | |
3mtf | A3F | Activin receptor type-1 | 2.7.11.30 | 0.508 | |
3ncg | BK1 | Calmodulin-domain protein kinase 1, putative | / | 0.506 | |
3ttj | JBI | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.506 | |
4c3f | 7KW | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.506 | |
1byg | STU | Tyrosine-protein kinase CSK | / | 0.505 | |
4bib | IEO | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.505 | |
5ar4 | SB2 | Receptor-interacting serine/threonine-protein kinase 2 | 2.7.11.1 | 0.505 | |
1u4d | DBQ | Activated CDC42 kinase 1 | / | 0.503 | |
3r04 | UNQ | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.503 | |
4ic7 | ANP | Mitogen-activated protein kinase 7 | 2.7.11.24 | 0.503 | |
2o0u | C0M | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.501 | |
4lop | SB4 | Mitogen-activated protein kinase 14 | / | 0.501 | |
5e8w | STU | TGF-beta receptor type-1 | 2.7.11.30 | 0.501 | |
1csn | ATP | Casein kinase I homolog 1 | 2.7.11.1 | 0.500 | |
4loq | SB4 | Mitogen-activated protein kinase 14 | / | 0.500 | |
4dym | IYZ | Activin receptor type-1 | 2.7.11.30 | 0.499 | |
3a99 | ANP | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.497 | |
3f69 | XDR | Serine/threonine-protein kinase PknB | 2.7.11.1 | 0.497 | |
3mvl | 38P | Mitogen-activated protein kinase 14 | / | 0.497 | |
4bi1 | ZO6 | Dual specificity protein kinase TTK | 2.7.12.1 | 0.497 | |
1yi4 | ADN | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.496 | |
4c4j | X21 | Dual specificity protein kinase TTK | 2.7.12.1 | 0.496 | |
4riy | ADP | Epidermal growth factor receptor | 2.7.10.1 | 0.495 | |
4bgg | 844 | Activin receptor type-1 | 2.7.11.30 | 0.493 | |
3gc9 | B45 | Mitogen-activated protein kinase 11 | 2.7.11.24 | 0.492 | |
1pme | SB2 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.490 | |
1szm | BI4 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.489 | |
2iw9 | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.489 | |
2j0l | ANP | Focal adhesion kinase 1 | 2.7.10.2 | 0.489 | |
3say | OFT | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.489 | |
4hgl | 0YO | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.489 | |
4k0y | 1OA | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.489 | |
2vz6 | FEF | Calcium/calmodulin-dependent protein kinase type II subunit alpha | 2.7.11.17 | 0.488 | |
3hl7 | I47 | Mitogen-activated protein kinase 14 | / | 0.488 | |
4feq | 0T8 | Tyrosine-protein kinase receptor TYRO3 | 2.7.10.1 | 0.488 | |
3gu8 | 3GU | Death-associated protein kinase 1 | 2.7.11.1 | 0.487 | |
4ewq | MWL | Mitogen-activated protein kinase 14 | / | 0.487 | |
5amn | DTQ | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.487 | |
4bkz | 1WS | Maternal embryonic leucine zipper kinase | 2.7.11.1 | 0.486 | |
4kb8 | 1QO | Casein kinase I isoform delta | 2.7.11.1 | 0.486 | |
2h8h | H8H | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.485 | |
2hy8 | 1ST | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.485 | |
3kf7 | L9G | Mitogen-activated protein kinase 14 | / | 0.485 | |
3w33 | W19 | Epidermal growth factor receptor | 2.7.10.1 | 0.485 | |
4gih | 0X5 | Non-receptor tyrosine-protein kinase TYK2 | 2.7.10.2 | 0.485 | |
4mbl | 26L | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.485 | |
2br1 | PFP | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.484 | |
3jy0 | LYG | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.484 | |
2exc | JNK | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.483 | |
2iw8 | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.483 | |
4eok | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.483 | |
4eor | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.483 | |
4z64 | ILE_THR_GLN_TYS_TYS | Phytosulfokine receptor 1 | 2.7.11.1 | 0.483 | |
1h1s | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.482 | |
1oiy | N41 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.482 | |
1zar | ADP | RIO-type serine/threonine-protein kinase Rio2 | 2.7.11.1 | 0.482 | |
4ft7 | H3K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.482 | |
4g16 | 0VM | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.482 | |
4qmx | H8H | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.482 | |
1gih | 1PU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.481 | |
3jxw | LXG | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.481 | |
3mpa | SB2 | Mitogen-activated protein kinase 14 | / | 0.481 | |
3roc | 29A | Mitogen-activated protein kinase 14 | / | 0.481 | |
4hgt | 15G | Casein kinase I isoform delta | 2.7.11.1 | 0.481 | |
1oi9 | N20 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.480 | |
3c50 | ADP | Rhodopsin kinase | / | 0.480 | |
3oqk | S52 | Renin | 3.4.23.15 | 0.480 | |
3r2b | 05B | MAP kinase-activated protein kinase 2 | 2.7.11.1 | 0.480 | |
3tti | KBI | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.480 | |
2x1n | X1N | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.479 | |
2zdt | 46C | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.479 | |
4zse | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.479 | |
2iw6 | QQ2 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.478 | |
3zew | STU | Ephrin type-B receptor 4 | 2.7.10.1 | 0.478 | |
4ft5 | H2K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.478 | |
4ih8 | B43 | Calmodulin-domain protein kinase 1 | / | 0.478 | |
2chz | 093 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.477 | |
2obj | VRV | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.477 | |
3hmm | 855 | TGF-beta receptor type-1 | 2.7.11.30 | 0.477 | |
3she | I85 | MAP kinase-activated protein kinase 3 | 2.7.11.1 | 0.477 | |
2cke | IQU | Death-associated protein kinase 2 | / | 0.476 | |
4dtk | 7LI | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.476 | |
4gfo | 0X2 | Non-receptor tyrosine-protein kinase TYK2 | 2.7.10.2 | 0.476 | |
2itt | AEE | Epidermal growth factor receptor | 2.7.10.1 | 0.475 | |
2ycs | NXP | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.475 | |
3bu5 | ATP | Insulin receptor | 2.7.10.1 | 0.475 | |
3nww | 3NW | Mitogen-activated protein kinase 14 | / | 0.475 | |
1ywr | LI9 | Mitogen-activated protein kinase 14 | / | 0.474 | |
2j0k | 4ST | Focal adhesion kinase 1 | 2.7.10.2 | 0.474 | |
2xj1 | XJ1 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.474 | |
3hzt | J60 | Calmodulin-like domain protein kinase isoform 3 | / | 0.474 | |
4aac | AAV | Mitogen-activated protein kinase 14 | / | 0.474 | |
4ez5 | 0RS | Cyclin-dependent kinase 6 | 2.7.11.22 | 0.474 | |
4kiq | 1RA | Mitogen-activated protein kinase 14 | / | 0.474 | |
1vjy | 460 | TGF-beta receptor type-1 | 2.7.11.30 | 0.473 | |
2ghm | LIC | Mitogen-activated protein kinase 14 | / | 0.473 | |
3fls | FLS | Mitogen-activated protein kinase 14 | / | 0.473 | |
3igo | ANP | Calmodulin-domain protein kinase 1, putative | / | 0.473 | |
4bco | T6Q | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.473 | |
4bzo | 676 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.473 | |
1xr1 | ANP | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.472 | |
4c4h | 7RO | Dual specificity protein kinase TTK | 2.7.12.1 | 0.472 | |
4f65 | 0S9 | Fibroblast growth factor receptor 1 | / | 0.472 | |
4idv | 13V | Mitogen-activated protein kinase kinase kinase 14 | 2.7.11.25 | 0.472 | |
3tki | S25 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.471 | |
4fv9 | E71 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.471 | |
4gk2 | L66 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.471 | |
1ir3 | ANP | Insulin receptor | 2.7.10.1 | 0.470 | |
1k6c | MK1 | Gag-Pol polyprotein | 3.4.23.16 | 0.470 | |
2w05 | FRT | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.470 | |
1u54 | ACP | Activated CDC42 kinase 1 | / | 0.469 | |
1v0p | PVB | Cell division control protein 2 homolog | 2.7.11.22 | 0.469 | |
2o65 | MYF | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.469 | |
3oom | 507 | Activin receptor type-1 | 2.7.11.30 | 0.469 | |
3orm | AGS | Serine/threonine protein kinase | / | 0.469 | |
3vs7 | KS1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.469 | |
3wi6 | YRZ | MAP kinase-activated protein kinase 2 | 2.7.11.1 | 0.469 | |
4bcm | T7Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.469 | |
4k11 | 0J9 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.469 | |
4n70 | 2HX | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.469 | |
4xhg | ADP | Uncharacterized protein | / | 0.469 | |
1e8z | STU | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.468 | |
1k6t | XN1 | Gag-Pol polyprotein | 3.4.23.16 | 0.468 | |
1nvq | UCN | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.468 | |
3bgq | VX2 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.468 | |
3et7 | 349 | Protein-tyrosine kinase 2-beta | 2.7.10.2 | 0.468 | |
3s2p | PMU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.468 | |
4c02 | TAK | Activin receptor type-1 | 2.7.11.30 | 0.468 | |
4e4m | 0NH | Tyrosine-protein kinase JAK2 | / | 0.468 | |
4fv0 | EK3 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.468 | |
4fx3 | 60K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.468 | |
4hle | 17V | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.468 | |
3l8p | 0CE | Angiopoietin-1 receptor | 2.7.10.1 | 0.467 | |
4aa4 | QC0 | Mitogen-activated protein kinase 14 | / | 0.467 | |
4c4f | 7CE | Dual specificity protein kinase TTK | 2.7.12.1 | 0.467 | |
4k1b | 1OC | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.467 | |
4ux9 | ANP | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.467 | |
4yzc | STU | Serine/threonine-protein kinase/endoribonuclease IRE1 | 2.7.11.1 | 0.467 | |
4z61 | ILE_THR_GLN_TYS_TYS | Phytosulfokine receptor 1 | 2.7.11.1 | 0.467 | |
1k6p | XN3 | Gag-Pol polyprotein | 3.4.23.16 | 0.466 | |
1zyj | BI5 | Mitogen-activated protein kinase 14 | / | 0.466 | |
2dq7 | STU | Tyrosine-protein kinase Fyn | 2.7.10.2 | 0.466 | |
3a4p | DFQ | Hepatocyte growth factor receptor | 2.7.10.1 | 0.466 | |
3a62 | STU | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.466 | |
3hvc | GG5 | Mitogen-activated protein kinase 14 | / | 0.466 | |
4anw | O92 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.466 | |
4k18 | 1OB | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.466 | |
4kbc | 1QJ | Casein kinase I isoform delta | 2.7.11.1 | 0.466 | |
4ks8 | B49 | Serine/threonine-protein kinase PAK 6 | 2.7.11.1 | 0.466 | |
4mcv | 29K | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.466 | |
4qmz | B49 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.466 | |
1xjd | STU | Protein kinase C theta type | 2.7.11.13 | 0.465 | |
2etm | 7PY | Focal adhesion kinase 1 | 2.7.10.2 | 0.465 | |
2yit | YIT | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.465 | |
3mwu | BK3 | Calmodulin-domain protein kinase 1, putative | / | 0.465 | |
3vs1 | VSA | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.465 | |
4jq8 | KJ8 | Epidermal growth factor receptor | 2.7.10.1 | 0.465 | |
4nk9 | 2K5 | Fibroblast growth factor receptor 1 | / | 0.465 | |
4qmp | DKI | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.465 | |
5auw | QUE | Death-associated protein kinase 1 | 2.7.11.1 | 0.465 | |
1rw8 | 580 | TGF-beta receptor type-1 | 2.7.11.30 | 0.464 | |
2j2i | LY4 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.464 | |
2jed | LG8 | Protein kinase C theta type | 2.7.11.13 | 0.464 | |
3qu0 | X40 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.464 | |
3r02 | UNM | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.464 | |
3uix | Q17 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.464 | |
3umw | 596 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.464 | |
3umx | Q18 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.464 | |
4aoj | V4Z | High affinity nerve growth factor receptor | 2.7.10.1 | 0.464 | |
4b99 | R4L | Mitogen-activated protein kinase 7 | 2.7.11.24 | 0.464 | |
4hvi | 19S | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.464 | |
4nks | 2M2 | Fibroblast growth factor receptor 1 | / | 0.464 | |
5cvh | ADP | Casein kinase II subunit alpha | 2.7.11.1 | 0.464 | |
1aq1 | STU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.463 | |
1di8 | DTQ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.463 | |
1g5s | I17 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.463 | |
1gqt | ACP | Ribokinase | / | 0.463 | |
2q59 | 240 | Peroxisome proliferator-activated receptor gamma | / | 0.463 | |
2vwy | 7X5 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.463 | |
2xm9 | LWH | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.463 | |
3rk5 | 07Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.463 | |
4kio | G5K | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.463 | |
1p4f | DRG | Death-associated protein kinase 1 | 2.7.11.1 | 0.462 | |
1yi3 | LY2 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.462 | |
2pvn | P63 | Casein kinase II subunit alpha | 2.7.11.1 | 0.462 | |
3ddp | RC8 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.462 | |
4fuy | EK2 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.462 | |
4hgs | 15G | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.462 | |
4z63 | ILE_THR_GLN_TYS_TYS | Phytosulfokine receptor 1 | 2.7.11.1 | 0.462 | |
1ie3 | NAD | Malate dehydrogenase | / | 0.461 | |
2bts | U32 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.461 | |
2itn | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.461 | |
2itp | AEE | Epidermal growth factor receptor | 2.7.10.1 | 0.461 | |
2vww | 7X2 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.461 | |
3a4o | STU | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.461 | |
3cy2 | MB9 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.461 | |
3ma3 | 01I | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.461 | |
3nwq | 2NC | Gag-Pol polyprotein | 3.4.23.16 | 0.461 | |
3nwx | KVS | Gag-Pol polyprotein | 3.4.23.16 | 0.461 | |
4anx | 534 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.461 | |
4cfn | JYM | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.461 | |
4r8q | ADP | Mitotic checkpoint serine/threonine-protein kinase BUB1 | 2.7.11.1 | 0.461 | |
2c47 | 5ID | Casein kinase I isoform gamma-2 | / | 0.460 | |
2gcd | STU | Serine/threonine-protein kinase TAO2 | 2.7.11.1 | 0.460 | |
2ym6 | YM6 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.460 | |
3cy3 | JN5 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.460 | |
3fi3 | JK2 | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.460 | |
4bf2 | STU | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.460 | |
4bzn | UGX | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.460 | |
4fg7 | ATP | Calcium/calmodulin-dependent protein kinase type 1 | 2.7.11.17 | 0.460 | |
4l42 | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.460 | |
4lmu | QUE | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.460 | |
1e6e | FAD | NADPH:adrenodoxin oxidoreductase, mitochondrial | 1.18.1.6 | 0.459 | |
1pkg | ADP | Mast/stem cell growth factor receptor Kit | 2.7.10.1 | 0.459 | |
2bdj | HET | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.459 | |
2brh | DFW | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.459 | |
2xk9 | XK9 | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.459 | |
3b6z | CO7 | Enoyl reductase LovC | 1 | 0.459 | |
3bgp | VX1 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.459 | |
3fmj | FMJ | Mitogen-activated protein kinase 14 | / | 0.459 | |
3mfs | ANP | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.459 | |
3qai | XNN | Ketohexokinase | / | 0.459 | |
3u9n | 09H | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.459 | |
4a06 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.459 | |
5ap5 | 7RO | Dual specificity protein kinase TTK | 2.7.12.1 | 0.459 | |
5dpv | SKE | Aurora kinase A | 2.7.11.1 | 0.459 | |
1h1r | 6CP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.458 | |
1wbm | BLL | Pol protein | / | 0.458 | |
1yhs | STU | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.458 | |
2ghl | LIB | Mitogen-activated protein kinase 14 | / | 0.458 | |
2wou | ZZF | TGF-beta receptor type-1 | 2.7.11.30 | 0.458 | |
3m42 | HGF | MAP kinase-activated protein kinase 2 | 2.7.11.1 | 0.458 | |
3tmz | 06X | Cytochrome P450 2B4 | 1.14.14.1 | 0.458 | |
4dfl | 0K0 | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.458 | |
4eh6 | 0ON | Mitogen-activated protein kinase 14 | / | 0.458 | |
4flh | 14K | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.458 | |
4fr4 | STU | Serine/threonine-protein kinase 32A | 2.7.11.1 | 0.458 | |
4l52 | 1UL | Mitogen-activated protein kinase kinase kinase 7 | 2.7.11.25 | 0.458 | |
4wbo | ANW | Rhodopsin kinase | / | 0.458 | |
1oiu | N76 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.457 | |
1u59 | STU | Tyrosine-protein kinase ZAP-70 | 2.7.10.2 | 0.457 | |
2qo9 | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.457 | |
2wti | WTI | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.457 | |
2xrw | ANP | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.457 | |
3bgz | VX3 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.457 | |
3dt1 | P40 | Mitogen-activated protein kinase 14 | / | 0.457 | |
3vs4 | VSF | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.457 | |
4eoi | 1RO | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.457 | |
4fhk | 0U0 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.457 | |
4jlc | SU6 | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.457 | |
4o0w | ADN | Aurora kinase A | 2.7.11.1 | 0.457 | |
4qbj | NHM | Glycylpeptide N-tetradecanoyltransferase | 2.3.1.97 | 0.457 | |
1jpa | ANP | Ephrin type-B receptor 2 | 2.7.10.1 | 0.456 | |
2chl | DKI | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.456 | |
2rio | ADP | Serine/threonine-protein kinase/endoribonuclease IRE1 | 2.7.11.1 | 0.456 | |
3fmk | FMK | Mitogen-activated protein kinase 14 | / | 0.456 | |
3vbq | 0F5 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.456 | |
4bie | IE6 | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.456 | |
1stc | STU | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.455 | |
2j0m | 4ST | Focal adhesion kinase 1 | 2.7.10.2 | 0.455 | |
2vwz | 7X6 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.455 | |
2ycf | YCF | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.455 | |
3apf | BMW | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.455 | |
3fkl | FKL | Mitogen-activated protein kinase 14 | / | 0.455 | |
3ggf | GVD | Serine/threonine-protein kinase 26 | / | 0.455 | |
3my5 | RFZ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.455 | |
3q92 | XNB | Ketohexokinase | / | 0.455 | |
3uvq | FS8 | Mitogen-activated protein kinase 14 | / | 0.455 | |
4ia2 | BIV | Vitamin D3 receptor A | / | 0.455 | |
4kip | 1R9 | Mitogen-activated protein kinase 14 | / | 0.455 | |
4xf7 | ACP | Carbohydrate/pyrimidine kinase, PfkB family | / | 0.455 | |
5ajq | DB8 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.455 | |
1qcf | PP1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.454 | |
2dfv | NAD | L-threonine 3-dehydrogenase | / | 0.454 | |
2hy0 | 306 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.454 | |
2pz5 | ACP | Fibroblast growth factor receptor 2 | / | 0.454 | |
2uzl | C94 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.454 | |
3cxw | 7CP | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.454 | |
3ddq | RRC | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.454 | |
3kn5 | ANP | Ribosomal protein S6 kinase alpha-5 | 2.7.11.1 | 0.454 | |
3v5l | 0G1 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.454 | |
4fv7 | E94 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.454 | |
4hvh | 19R | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.454 | |
4iwq | 1FV | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.454 | |
4mwh | ATP | Casein kinase II subunit alpha | 2.7.11.1 | 0.454 | |
4ogr | ADN | Cyclin-dependent kinase 9 | 2.7.11.22 | 0.454 | |
4pkl | 1GH | Uncharacterized protein | / | 0.454 | |
5dgz | L20 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.454 | |
2bil | BI1 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.453 | |
2hog | 710 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.453 | |
2itq | ITQ | Epidermal growth factor receptor | 2.7.10.1 | 0.453 | |
2itz | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.453 | |
2pvh | P19 | Casein kinase II subunit alpha | 2.7.11.1 | 0.453 | |
3a9w | NAD | NDP-sugar epimerase | / | 0.453 | |
3fhy | ATP | Pyridoxal kinase | 2.7.1.35 | 0.453 | |
3kvx | FMY | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.453 | |
3vs5 | VSG | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.453 | |
4bfm | ANP | Maternal embryonic leucine zipper kinase | 2.7.11.1 | 0.453 | |
4lm5 | Q17 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.453 | |
4wkq | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.453 | |
5aac | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.453 | |
5dt0 | SKE | Aurora kinase A | 2.7.11.1 | 0.453 | |
5e8x | STU | TGF-beta receptor type-1 | 2.7.11.30 | 0.453 | |
1ke7 | LS3 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.452 | |
1o6y | ACP | Serine/threonine-protein kinase PknB | 2.7.11.1 | 0.452 | |
1qpj | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.452 | |
2w1f | L0F | Aurora kinase A | 2.7.11.1 | 0.452 | |
2yn8 | STU | Ephrin type-B receptor 4 | 2.7.10.1 | 0.452 | |
3dog | NNN | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.452 | |
3hx4 | ANP | Calmodulin-domain protein kinase 1 | / | 0.452 | |
3oqf | S51 | Renin | 3.4.23.15 | 0.452 | |
3q4z | ANP | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.452 | |
4dee | ADP | Aurora kinase A | 2.7.11.1 | 0.452 | |
4dfn | 0K1 | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.452 | |
4g6o | E28 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.452 | |
4grb | 0XG | Casein kinase II subunit alpha | 2.7.11.1 | 0.452 | |
4j97 | ACP | Fibroblast growth factor receptor 2 | / | 0.452 | |
4jqe | ANP | Casein kinase II subunit alpha | 2.7.11.1 | 0.452 | |
1c70 | L75 | Protease | / | 0.451 | |
1kbq | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.451 | |
1ke6 | LS2 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.451 | |
1qpd | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.451 | |
1tvo | FRZ | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.451 | |
2h96 | 893 | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.451 | |
2x2l | X2L | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.451 | |
2xj2 | 985 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.451 | |
4anv | 751 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.451 | |
4awi | AQ2 | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.451 | |
4gk4 | L90 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.451 | |
4kik | KSA | Inhibitor of nuclear factor kappa-B kinase subunit beta | 2.7.11.10 | 0.451 | |
4qmt | H1N | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.451 | |
1ogu | ST8 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.450 | |
1pnv | TYD | dTDP-epi-vancosaminyltransferase | 2.4.1.311 | 0.450 | |
2cgw | 3C3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.450 | |
2wqe | ADP | Aurora kinase A | 2.7.11.1 | 0.450 | |
2x9f | X9F | Ephrin type-B receptor 4 | 2.7.10.1 | 0.450 | |
3bkb | STU | Tyrosine-protein kinase Fes/Fps | 2.7.10.2 | 0.450 | |
4a4v | YFD | Peroxisome proliferator-activated receptor gamma | / | 0.450 | |
1oir | HDY | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.449 | |
2g22 | 6IG | Renin | 3.4.23.15 | 0.449 | |
2hxl | 422 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.449 | |
2qa2 | FAD | Polyketide oxygenase CabE | / | 0.449 | |
2vu3 | LZE | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.449 | |
2vx1 | 7X8 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.449 | |
3g5s | FAD | Methylenetetrahydrofolate--tRNA-(uracil-5-)-methyltransferase TrmFO | / | 0.449 | |
3iw4 | LW4 | Protein kinase C alpha type | 2.7.11.13 | 0.449 | |
3jpv | 1DR | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.449 | |
3qtz | X42 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.449 | |
3rkb | 12Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.449 | |
3vqu | O22 | Dual specificity protein kinase TTK | 2.7.12.1 | 0.449 | |
3vs2 | VSB | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.449 | |
3zh8 | C58 | Protein kinase C iota type | 2.7.11.13 | 0.449 | |
4ezl | 0SE | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.449 | |
4g6n | EK0 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.449 | |
4i0r | 1B4 | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.449 | |
4i41 | MIX | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.449 | |
4jr7 | GNP | Casein kinase II subunit alpha | 2.7.11.1 | 0.449 | |
4nka | 2K7 | Fibroblast growth factor receptor 1 | / | 0.449 | |
5e8y | STU | TGF-beta receptor type-2 | 2.7.11.30 | 0.449 | |
1bvr | THT | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.448 | |
1bxo | PP7 | Penicillopepsin-1 | 3.4.23.20 | 0.448 | |
1m17 | AQ4 | Epidermal growth factor receptor | 2.7.10.1 | 0.448 | |
1okz | UCN | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.448 | |
1q41 | IXM | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.448 | |
1wvx | BD4 | Death-associated protein kinase 1 | 2.7.11.1 | 0.448 | |
1xl2 | 189 | Gag-Pol polyprotein | 3.4.23.16 | 0.448 | |
1zao | ATP | RIO-type serine/threonine-protein kinase Rio2 | 2.7.11.1 | 0.448 | |
2c7x | NRB | Cytochrome P450 monooxygenase PikC | / | 0.448 | |
2e9u | A25 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.448 | |
2gs7 | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.448 | |
3nxe | 2NC | Protease | / | 0.448 | |
3oro | AGS | Serine/threonine protein kinase | / | 0.448 | |
4c4i | X20 | Dual specificity protein kinase TTK | 2.7.12.1 | 0.448 | |
4cy8 | FDA | 2-hydroxybiphenyl-3-monooxygenase | / | 0.448 | |
4d0l | 093 | Phosphatidylinositol 4-kinase beta | 2.7.1.67 | 0.448 | |
4xcv | NDP | Probable hydroxyacid dehydrogenase protein | / | 0.448 | |
5ack | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.448 | |
1hii | C20 | Gag-Pol polyprotein | / | 0.447 | |
1unl | RRC | Cyclin-dependent-like kinase 5 | 2.7.11.1 | 0.447 | |
2brb | PFQ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.447 | |
2brm | DFZ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.447 | |
2chx | 090 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.447 | |
2o2u | 738 | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.447 | |
2vgo | AD5 | Aurora kinase B-A | 2.7.11.1 | 0.447 | |
2wtd | ZZK | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.447 | |
3c4z | ADP | Rhodopsin kinase | / | 0.447 | |
3gu6 | ADP | Death-associated protein kinase 1 | 2.7.11.1 | 0.447 | |
3nux | 3NV | Cyclin-dependent kinase 6 | 2.7.11.22 | 0.447 | |
4bcn | T9N | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.447 | |
4bcq | TJF | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.447 | |
4c4g | 7RO | Dual specificity protein kinase TTK | 2.7.12.1 | 0.447 | |
4e73 | 0NR | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.447 | |
4fkw | 62K | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.447 | |
4qmw | KS1 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.447 | |
4xgx | ADP | FAD:protein FMN transferase | / | 0.447 | |
5drd | ATP | Aurora kinase A | 2.7.11.1 | 0.447 | |
5dt4 | ATP | Aurora kinase A | 2.7.11.1 | 0.447 | |
1rfv | ADP | Pyridoxal kinase | 2.7.1.35 | 0.446 | |
1xws | BI1 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.446 | |
2bal | PQA | Mitogen-activated protein kinase 14 | / | 0.446 | |
2fgi | PD1 | Fibroblast growth factor receptor 1 | / | 0.446 | |
2vx0 | 7X7 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.446 | |
2zv9 | PP2 | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.446 | |
3cbl | STU | Tyrosine-protein kinase Fes/Fps | 2.7.10.2 | 0.446 | |
3i4b | Z48 | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.446 | |
3s4q | NK0 | Mitogen-activated protein kinase 14 | / | 0.446 | |
3tkh | 07S | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.446 | |
3vs0 | VS0 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.446 | |
3vs6 | VSH | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.446 | |
3w32 | W32 | Epidermal growth factor receptor | 2.7.10.1 | 0.446 | |
3zc6 | VFC | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.446 | |
4ans | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.446 | |
4foc | 0UU | ALK tyrosine kinase receptor | 2.7.10.1 | 0.446 | |
4g3e | 0WC | Mitogen-activated protein kinase kinase kinase 14 | 2.7.11.25 | 0.446 | |
4iwo | 1H4 | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.446 | |
4qpm | ADP | Mitotic checkpoint serine/threonine-protein kinase BUB1 | 2.7.11.1 | 0.446 | |
4u97 | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.446 | |
1e7v | LY2 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.445 | |
1r78 | FMD | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.445 | |
1tqm | ANP | RIO-type serine/threonine-protein kinase Rio2 | 2.7.11.1 | 0.445 | |
2bro | DF2 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.445 | |
2c0t | L3G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.445 | |
2j0j | 4ST | Focal adhesion kinase 1 | 2.7.10.2 | 0.445 | |
2pwl | ACP | Fibroblast growth factor receptor 2 | / | 0.445 | |
3t11 | 3T1 | Gag-Pol polyprotein | 3.4.23.16 | 0.445 | |
3tea | 4CO | 4-hydroxybenzoyl-CoA thioesterase | 3.1.2.23 | 0.445 | |
3w1f | 1O5 | Dual specificity protein kinase TTK | 2.7.12.1 | 0.445 | |
4ful | 0VU | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.445 | |
4hvb | 19P | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.445 | |
1e9h | INR | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.444 | |
1h1q | 2A6 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.444 | |
1nvs | UCM | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.444 | |
1xdd | AAY | Integrin alpha-L | / | 0.444 | |
2e9o | A58 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.444 | |
2hxq | 373 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.444 | |
2ivu | ZD6 | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.444 | |
2of2 | 547 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.444 | |
2xik | J60 | Serine/threonine-protein kinase 25 | 2.7.11.1 | 0.444 | |
2yir | YIR | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.444 | |
3ad6 | KSC | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.444 | |
3kc3 | MK2 | MAP kinase-activated protein kinase 2 | 2.7.11.1 | 0.444 | |
3lj3 | WYE | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.444 | |
4fod | 0UV | ALK tyrosine kinase receptor | 2.7.10.1 | 0.444 | |
4gmy | 0X5 | Tyrosine-protein kinase JAK2 | / | 0.444 | |
4lfi | GNP | Casein kinase II subunit alpha | 2.7.11.1 | 0.444 | |
4oj4 | DIF | Peroxisome proliferator-activated receptor gamma | / | 0.444 | |
5dr9 | SKE | Aurora kinase A | 2.7.11.1 | 0.444 | |
1gii | 1PU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.443 | |
1ig1 | ANP | Death-associated protein kinase 1 | 2.7.11.1 | 0.443 | |
1men | GAR | Trifunctional purine biosynthetic protein adenosine-3 | 2.1.2.2 | 0.443 | |
1py5 | PY1 | TGF-beta receptor type-1 | 2.7.11.30 | 0.443 | |
2b52 | D42 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.443 | |
2bdf | 24A | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.443 | |
2c0o | L2G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.443 | |
2ijm | ADP | Focal adhesion kinase 1 | 2.7.10.2 | 0.443 | |
2j9m | PY8 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.443 | |
2nry | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.443 | |
2pzp | ACP | Fibroblast growth factor receptor 2 | / | 0.443 | |
2x3n | FAD | Probable FAD-dependent monooxygenase | / | 0.443 | |
3aw9 | NAD | NAD-dependent epimerase/dehydratase | / | 0.443 | |
3b8r | 887 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.443 | |
3ckt | YDP | Gag-Pol polyprotein | 3.4.23.16 | 0.443 | |
3dcv | 55E | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.443 | |
3h0s | B38 | Acetyl-CoA carboxylase | / | 0.443 | |
3lfq | A28 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.443 | |
3nyn | SGV | G protein-coupled receptor kinase 6 | 2.7.11.16 | 0.443 | |
3ort | AGS | Serine/threonine protein kinase | / | 0.443 | |
3pe6 | ZYH | Monoglyceride lipase | / | 0.443 | |
4btk | DTQ | Tau-tubulin kinase 1 | 2.7.11.1 | 0.443 | |
4dn5 | AGS | Mitogen-activated protein kinase kinase kinase 14 | 2.7.11.25 | 0.443 | |
4fsn | A58 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.443 | |
4gj2 | 0XH | Non-receptor tyrosine-protein kinase TYK2 | 2.7.10.2 | 0.443 | |
4l3j | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.443 | |
5auu | LU2 | Death-associated protein kinase 1 | 2.7.11.1 | 0.443 | |
1m2r | MNY | Casein kinase II subunit alpha | 2.7.11.1 | 0.442 | |
1nxk | STU | MAP kinase-activated protein kinase 2 | 2.7.11.1 | 0.442 | |
1ny3 | ADP | MAP kinase-activated protein kinase 2 | 2.7.11.1 | 0.442 | |
2bfy | H1N | Aurora kinase B-A | 2.7.11.1 | 0.442 | |
2c6o | 4SP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.442 | |
2e9n | 76A | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.442 | |
2pzi | AXX | Serine/threonine-protein kinase PknG | 2.7.11.1 | 0.442 | |
2w0j | ZAT | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.442 | |
2w9s | TOP | Dihydrofolate reductase type 1 from Tn4003 | 1.5.1.3 | 0.442 | |
2ycr | HCW | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.442 | |
3a1n | NAD | NDP-sugar epimerase | / | 0.442 | |
3cyl | VIT | Basic phospholipase A2 homolog piratoxin-2 | / | 0.442 | |
3elj | GS7 | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.442 | |
3k5u | PFQ | Aurora kinase A | 2.7.11.1 | 0.442 | |
3lfn | A27 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.442 | |
3r9d | X6B | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.442 | |
3rni | 21Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.442 | |
3s0o | 50Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.442 | |
3zsi | 52P | Mitogen-activated protein kinase 14 | / | 0.442 | |
4anq | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.442 | |
4aw3 | MYV | Mycinamicin IV hydroxylase/epoxidase | / | 0.442 | |
4bcp | T3C | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.442 | |
4c34 | STU | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.442 | |
4cql | NAD | Estradiol 17-beta-dehydrogenase 8 | 1.1.1.62 | 0.442 | |
4erw | STU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.442 | |
4hvg | 19Q | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.442 | |
4mxa | BK7 | Calmodulin-like domain protein kinase isoenzyme gamma, related | / | 0.442 | |
4mxx | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.442 | |
1bxq | PP8 | Penicillopepsin-1 | 3.4.23.20 | 0.441 | |
1pmn | 984 | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.441 | |
1zz2 | B11 | Mitogen-activated protein kinase 14 | / | 0.441 | |
2bik | BI1 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.441 | |
2i1m | 5CN | Macrophage colony-stimulating factor 1 receptor | 2.7.10.1 | 0.441 | |
2ivv | PP1 | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.441 | |
2vwx | 7X4 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.441 | |
2wec | PP5 | Penicillopepsin-1 | 3.4.23.20 | 0.441 | |
2wpa | 889 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.441 | |
2y46 | MIV | Mycinamicin IV hydroxylase/epoxidase | / | 0.441 | |
3ac3 | KSH | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.441 | |
3el5 | 1UN | Gag-Pol polyprotein | / | 0.441 | |
3iw7 | IPK | Mitogen-activated protein kinase 14 | / | 0.441 | |
3t2z | FAD | Sulfide-quinone reductase | / | 0.441 | |
3vry | B43 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.441 | |
4cki | ADN | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.441 | |
4dgn | LU2 | Casein kinase II subunit alpha | 2.7.11.1 | 0.441 | |
4ft3 | H1K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.441 | |
4h3y | SAH | tRNA (guanine-N(1)-)-methyltransferase | / | 0.441 | |
4l45 | 5FI | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.441 | |
5dqr | FAD | 7-hydroxymethyl chlorophyll a reductase, chloroplastic | 1.17.7.2 | 0.441 | |
5dt3 | ATP | Aurora kinase A | 2.7.11.1 | 0.441 | |
1dhr | NAD | Dihydropteridine reductase | 1.5.1.34 | 0.440 | |
1oky | STU | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.440 | |
1ouy | 094 | Mitogen-activated protein kinase 14 | / | 0.440 | |
2fb8 | 215 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.440 | |
2nru | T12 | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.440 | |
2p4y | C03 | Peroxisome proliferator-activated receptor gamma | / | 0.440 | |
2pmo | HMD | Protein kinase 7 | / | 0.440 | |
2pvl | P55 | Casein kinase II subunit alpha | 2.7.11.1 | 0.440 | |
2xru | 400 | Aurora kinase A | 2.7.11.1 | 0.440 | |
2yfe | YFE | Peroxisome proliferator-activated receptor gamma | / | 0.440 | |
3fi4 | FI4 | Mitogen-activated protein kinase 14 | / | 0.440 | |
3flz | FLZ | Mitogen-activated protein kinase 14 | / | 0.440 | |
3mqe | 416 | Prostaglandin G/H synthase 2 | 1.14.99.1 | 0.440 | |
3ocg | OCG | Mitogen-activated protein kinase 14 | / | 0.440 | |
3oev | 3OE | Proteasome subunit beta type-5 | 3.4.25.1 | 0.440 | |
3oev | 3OE | Proteasome subunit beta type-6 | 3.4.25.1 | 0.440 | |
3qa2 | XNA | Ketohexokinase | / | 0.440 | |
3r7v | Z02 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.440 | |
4anm | WUL | Casein kinase II subunit alpha | 2.7.11.1 | 0.440 | |
4eol | 1RO | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.440 | |
4h4u | NDP | Biphenyl dioxygenase ferredoxin reductase subunit | / | 0.440 | |
4nif | ANP | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.440 | |
4o70 | 1QK | Bromodomain-containing protein 4 | / | 0.440 | |
4xum | IMN | Peroxisome proliferator-activated receptor gamma | / | 0.440 | |
5dmz | ADP | Mitotic checkpoint serine/threonine-protein kinase BUB1 | 2.7.11.1 | 0.440 | |
5e92 | ANP | TGF-beta receptor type-2 | 2.7.11.30 | 0.440 |